Skip to content

Medical-device intelligence

Roche Diagnostics Operations, inc.: FDA clearances and recalls

Research Roche Diagnostics Operations, inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

2 clearance records and 151 recall records in the covered releases, across 1 source company names and 55 product codes. Dated history runs from Nov 25, 13 to Jan 20, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202501
December 202500
January 202601
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

153 matching records
Device / recordCompany in FDA recordSourceSource date
S2 Fluid Pack on the Cobas b 221 system- Catalog Number 03260925184 Blood Gas and Electrolytes Analyzer; The Roche Diagnostics Omni S Analyzer i…Z-2330-2015 · CHLRoche Diagnostics Operations, Inc.RecallAug 5, 2015FDA classification date
Cholesterol CHOD-PAP. In vitro diagnostic reagent system intended for use on the Hitachi systems for The quantitative determination of total cho…Z-1920-2015 · CHHRoche Diagnostics Operations, Inc.RecallJun 27, 2015FDA classification date
Cholesterol Gen.2. The cassette COBAS Integra Cholesterol Gen.2 (CHOL2) contains an in vitro diagnostic reagent system intended for use on COBAS…Z-1921-2015 · CHHRoche Diagnostics Operations, Inc.RecallJun 27, 2015FDA classification date
Creatinine Plus. Intended for use on Hitachi/MODULAR systems for the quantitative determination of the creatinine concentration in serum, plasma…Z-1922-2015 · JJERoche Diagnostics Operations, Inc.RecallJun 27, 2015FDA classification date
Creatinine Plus ver. 2. Intended for use on COBAS INTEGRA systems , cobas c111, and cobas c systems for the quantitative determination of the cr…Z-1923-2015 · JFYRoche Diagnostics Operations, Inc.RecallJun 27, 2015FDA classification date
HDL-Cholesterol gen.3. For the quantitative determination of high-density lipoprotein Cholesterol (HDL-C) in serum and plasma.Z-1924-2015 · LBSRoche Diagnostics Operations, Inc.RecallJun 27, 2015FDA classification date
HDL-Cholesterol plus gen.3.; and Small Supersized Intended for use on COBAS Integra 800 and 400 plus systems, cobas c111, and cobas c systems fo…Z-1925-2015 · LBSRoche Diagnostics Operations, Inc.RecallJun 27, 2015FDA classification date
Lactate. Intended for use on COBAS INTEGRA 800 and 400 plus systems, cobas c111, Roche/Hitachi MODULAR systems, and cobas c systems for the quan…Z-1926-2015 · CFJRoche Diagnostics Operations, Inc.RecallJun 27, 2015FDA classification date
LDL-Cholesterol gen.2. The Boehringer Mannheim Direct LDL-Cholesterol test in intended for the quantitative determination of low-density lipopr…Z-1927-2015 · MRRRoche Diagnostics Operations, Inc.RecallJun 27, 2015FDA classification date
LDL-Cholesterol plus gen.2. The Boehringer Mannheim Direct LDL-Cholesterol test in intended for the quantitative determination of low-density l…Z-1928-2015 · LBRRoche Diagnostics Operations, Inc.RecallJun 27, 2015FDA classification date
Triglycerides GPO. In vitro test for the quantitative determination of triglycerides in human serum and plasma on the COBAS Integra 800 and 400 …Z-1929-2015 · JJERoche Diagnostics Operations, Inc.RecallJun 27, 2015FDA classification date
Triglycerides/Glycerol Blanked. In vitro test for the quantitative determination of triglycerides in human serum and plasma or Roche/Hitachi MOD…Z-1930-2015 · CDTRoche Diagnostics Operations, Inc.RecallJun 27, 2015FDA classification date
Uric Acid plus ver.2 In vitro test for the quantitative determination of uric acid in human serum, plasma and urine or Roche/Hitachi MODULAR sys…Z-1931-2015 · KNKRoche Diagnostics Operations, Inc.RecallJun 27, 2015FDA classification date
Homocysteine test system - Homocysteine Reagent. 05385415190; Homocysteine 100 Tests, cobas c, COBAS INTEGRA Homocysteine Enzymatic Assay is an …Z-1622-2015 · LPSRoche Diagnostics Operations, Inc.RecallMay 15, 2015FDA classification date
Cobas b 221 (versions 5 and 6) Blood Gas and Electrolytes AnalyzerZ-1041-2015 · CGARoche Diagnostics Operations, Inc.RecallFeb 2, 2015FDA classification date
ACCU-CHEK Tender I 13/60 10 pieces Product Usage: Usage: Intended for the infusion and/or injection of fluids into the body below the surface o…Z-0883-2015 · FPARoche Diagnostics Operations, Inc.RecallDec 30, 2014FDA classification date
ACCU-CHEK Tender I 13/80 10 pieces Product Usage: Intended for the infusion and/or injection of fluids into the body below the surface of the sk…Z-0884-2015 · FPARoche Diagnostics Operations, Inc.RecallDec 30, 2014FDA classification date
ACCU-CHEK Tender I 13/110 10 pieces Product Usage: Intended for the infusion and/or injection of fluids into the body below the surface of the s…Z-0885-2015 · FPARoche Diagnostics Operations, Inc.RecallDec 30, 2014FDA classification date
ACCU-CHEK Tender I 17/60 10 pieces Product Usage: Intended for the infusion and/or injection of fluids into the body below the surface of the sk…Z-0886-2015 · FPARoche Diagnostics Operations, Inc.RecallDec 30, 2014FDA classification date
ACCU-CHEK Tender I 17/80 10 pieces Product Usage: Intended for the infusion and/or injection of fluids into the body below the surface of the sk…Z-0887-2015 · FPARoche Diagnostics Operations, Inc.RecallDec 30, 2014FDA classification date
ACCU-CHEK Tender I 17/110 10 pieces Product Usage: Intended for the infusion and/or injection of fluids into the body below the surface of the s…Z-0888-2015 · FPARoche Diagnostics Operations, Inc.RecallDec 30, 2014FDA classification date
ACCU-CHEK Tender II 13/60 10 + 10 pieces Product Usage: Intended for the infusion and/or injection of fluids into the body below the surface of …Z-0889-2015 · FPARoche Diagnostics Operations, Inc.RecallDec 30, 2014FDA classification date
ACCU-CHEK Tender II 13/80 10 + 10 pieces Product Usage: Intended for the infusion and/or injection of fluids into the body below the surface of …Z-0890-2015 · FPARoche Diagnostics Operations, Inc.RecallDec 30, 2014FDA classification date
ACCU-CHEK Tender II 13/110 10 + 10 pieces Product Usage: Intended for the infusion and/or injection of fluids into the body below the surface of…Z-0891-2015 · FPARoche Diagnostics Operations, Inc.RecallDec 30, 2014FDA classification date
ACCU-CHEK Tender II 17/60 10 + 10 pieces Product Usage: Intended for the infusion and/or injection of fluids into the body below the surface of …Z-0892-2015 · FPARoche Diagnostics Operations, Inc.RecallDec 30, 2014FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗